264 related articles for article (PubMed ID: 7882280)
1. Prophylactic cranial irradiation in limited-stage small cell lung cancer.
Liengswangwong V; Bonner JA; Shaw EG; Foote RL; Frytak S; Richardson RL; Creagan ET; Eagan RT; Su JQ
Cancer; 1995 Mar; 75(6):1302-9. PubMed ID: 7882280
[TBL] [Abstract][Full Text] [Related]
2. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
Shaw EG; Su JQ; Eagan RT; Jett JR; Maksymiuk AW; Deigert FA
J Clin Oncol; 1994 Nov; 12(11):2327-32. PubMed ID: 7964948
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
Alshehadat S; Sahmoun AE
Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
[TBL] [Abstract][Full Text] [Related]
6. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):807-11. PubMed ID: 7860392
[TBL] [Abstract][Full Text] [Related]
7. [Patterns of relapse in patients with small cell lung cancer--the effect of chest irradiation and prophylactic cranial irradiation combined with intensive chemotherapy on long-term survival].
Ueoka H; Ohnoshi T; Numata T; Kawahara S; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K; Uji H
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1581-7. PubMed ID: 1963910
[TBL] [Abstract][Full Text] [Related]
8. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
[TBL] [Abstract][Full Text] [Related]
9. A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer.
Rosenstein M; Armstrong J; Kris M; Shank B; Scher H; Fass D; Harrison L; Fuks Z; Leibel S
Int J Radiat Oncol Biol Phys; 1992; 24(1):43-8. PubMed ID: 1324901
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effectiveness of "late" and "early" prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
Sas-Korczyńska B; Korzeniowski S; Wójcik E
Strahlenther Onkol; 2010 Jun; 186(6):315-9. PubMed ID: 20495970
[TBL] [Abstract][Full Text] [Related]
11. Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.
Brewster AE; Hopwood P; Stout R; Burt PA; Thatcher N
Radiother Oncol; 1995 Feb; 34(2):132-6. PubMed ID: 7597211
[TBL] [Abstract][Full Text] [Related]
12. Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer.
Slotman BJ; Njo KH; de Jonge A; Meyer OW; Karim AB
Lung Cancer; 1993 Dec; 10(3-4):199-208. PubMed ID: 8075967
[TBL] [Abstract][Full Text] [Related]
13. Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung.
Rubenstein JH; Dosoretz DE; Katin MJ; Blitzer PH; Salenius SA; Floody PA; Harwin WN; Teufel TE; Raymond MG; Reeves JA
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):329-37. PubMed ID: 7673020
[TBL] [Abstract][Full Text] [Related]
14. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
15. A 10-year experience with combined modality therapy for stage III small cell lung carcinoma.
Jacobs RH; Greenburg A; Bitran JD; Hoffman PC; Albain KS; Desser R; Potkul L; Golomb HM
Cancer; 1986 Nov; 58(10):2177-84. PubMed ID: 3019503
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
Grosshans DR; Meyers CA; Allen PK; Davenport SD; Komaki R
Cancer; 2008 Feb; 112(3):589-95. PubMed ID: 18098269
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer.
Brown PD; Bonner JA; Foote RL; Frytak S; Marks RS; Richardson RL; Creagan ET
Am J Clin Oncol; 2001 Dec; 24(6):556-61. PubMed ID: 11801753
[TBL] [Abstract][Full Text] [Related]
18. Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: report of a single institutional phase II trial.
Wolfson AH; Bains Y; Lu J; Etuk B; Sridhar K; Raub W; Markoe A
Am J Clin Oncol; 2001 Jun; 24(3):290-5. PubMed ID: 11404503
[TBL] [Abstract][Full Text] [Related]
19. Treatment of small cell lung cancer. Two-drug versus four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiation.
Niiranen A; Holsti P; Salmo M
Acta Oncol; 1989; 28(4):501-5. PubMed ID: 2551355
[TBL] [Abstract][Full Text] [Related]
20. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
